Home › Esperion Therapeutics Added to the NASDAQ Biotechnology Index
 

Keywords :   


Esperion Therapeutics Added to the NASDAQ Biotechnology Index

2013-12-24 02:03:23| Biotech - Topix.net

Esperion Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol lowering therapies for the treatment of hypercholesterolemia, today announced that the company has been added to the NASDAQ Biotechnology Index effective prior to the market ... (more)

Tags: index added nasdaq biotechnology

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »